News / Korea / yonhap_finance
Humedix Announces 5 Billion Won Treasury Stock Cancellation to Boost Shareholder Value
Health Technology · Pharmaceuticals: Major · yonhap_finance · 2026-09-10
200670
Humedix has decided to cancel 184,000 shares of its treasury stock, valued at 5 billion won, as part of its ongoing commitment to enhancing shareholder returns.
What Happened
Treasury Stock Cancellation: Humedix officially announced on the 10th that its board of directors has approved the cancellation of treasury shares worth approximately 5 billion won. The cancellation involves 184,000 common shares, which were acquired through open-market purchases since June.
Shareholder Return Policy: This move is part of the company's broader shareholder return strategy aimed at increasing corporate value. By reducing the total number of outstanding shares by 1.64%, the company seeks to improve earnings per share and overall market confidence.
Execution Details: The cancellation is scheduled to take place on the 21st, with the total value based on the book value of the acquired shares. This action reflects the company's proactive approach to managing its capital structure and rewarding its investors.
Management Outlook: CEO Kang Min-jong stated that the company remains committed to utilizing resources generated from business growth to secure future engines of development and maximize shareholder value. Humedix continues to prioritize long-term growth alongside investor-friendly financial policies.